← Back to Screener
Alpha Tau Medical Ltd. Ordinary Shares (DRTS)
Price$9.66
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)196.17%
Price vs S&P 500 (4W)21.84%
VGM Score91.00
Market Capitalization$953.15M
All Metrics
Book Value / Share (Quarterly)$0.77
P/TBV (Annual)2.01x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.37
Price vs S&P 500 (YTD)107.85%
EPS (TTM)$-0.66
10-Day Avg Trading Volume0.92M
EPS Excl Extra (TTM)$-0.66
EPS (Annual)$-0.53
ROI (Annual)-51.08%
Cash / Share (Quarterly)$0.85
ROA (Last FY)-40.35%
EBITD / Share (TTM)$-0.25
ROE (5Y Avg)-62.89%
Cash Flow / Share (Annual)$-0.37
P/B Ratio13.74x
P/B Ratio (Quarterly)8.97x
Net Income / Employee (Annual)$-352,300
Net Interest Coverage (TTM)-135.30x
ROA (TTM)-52.90%
EPS Incl Extra (Annual)$-0.53
Current Ratio (Annual)7.45x
Quick Ratio (Quarterly)7.68x
3-Month Avg Trading Volume0.47M
52-Week Price Return261.00%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.33
52-Week High$11.62
EPS Excl Extra (Annual)$-0.53
CapEx CAGR (5Y)10.01%
26-Week Price Return212.10%
Quick Ratio (Annual)7.35x
13-Week Price Return36.57%
Total Debt / Equity (Annual)0.08x
Current Ratio (Quarterly)7.79x
Enterprise Value$954.91M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.83
3-Month Return Std Dev81.09%
Net Income / Employee (TTM)$-470,000
ROE (Last FY)-55.29%
Net Interest Coverage (Annual)-3.06x
EPS Basic Excl Extra (Annual)$-0.53
Total Debt / Equity (Quarterly)0.09x
EPS Incl Extra (TTM)$-0.66
ROI (TTM)-67.79%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$1.53
Price vs S&P 500 (52W)232.79%
Year-to-Date Return118.79%
5-Day Price Return7.87%
EPS Normalized (Annual)$-0.53
ROA (5Y Avg)-39.41%
Month-to-Date Return29.86%
EBITD / Share (Annual)$-0.51
LT Debt / Equity (Annual)0.08x
ROI (5Y Avg)-60.79%
LT Debt / Equity (Quarterly)0.09x
EPS Basic Excl Extra (TTM)$-0.66
P/TBV (Quarterly)2.29x
P/B Ratio (Annual)5.47x
Book Value / Share (Annual)$0.88
Price vs S&P 500 (13W)26.82%
Beta1.19x
Revenue / Share (TTM)$0.00
ROE (TTM)-73.23%
52-Week Low$2.81
mGradeA
vgmGradeA
Show chart for
Earnings Surprise History
Q1 26-0.26est. -0.13
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.30
4.30
4.20
4.20
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DRTSAlpha Tau Medical Ltd. Ordinary Shares | — | — | A | $9.66 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
Alpha Tau Medical is a clinical-stage oncology company developing Alpha DaRT, a proprietary technology that harnesses alpha particles for localized radiation therapy to treat solid tumors. The technology leverages alpha particles' therapeutic properties while addressing their traditionally limited range. The company is advancing its clinical pipeline with operations based in Israel.